Literature DB >> 19883461

Guide to Receptors and Channels (GRAC), 4th Edition.

.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19883461      PMCID： PMC2884572          DOI： 10.1111/j.1476-5381.2009.00499.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  Guide to Receptors and Channels (GRAC), 3rd edition.

Authors:  S P H Alexander; A Mathie; J A Peters
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

2.  X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.

Authors:  P M Vanhoutte; P P Humphrey; M Spedding
Journal:  Pharmacol Rev       Date:  1996-03       Impact factor: 25.468
  2 in total
  372 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Nonsynaptic communication through ATP release from volume-activated anion channels in axons.

Authors:  R Douglas Fields; Yingchun Ni
Journal:  Sci Signal       Date:  2010-10-05       Impact factor: 8.192

3.  Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Authors:  L Fattore; Ms Spano; V Melis; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells.

Authors:  Grace G L Yue; Jun-Ting Fan; Julia K M Lee; Guang-Zhi Zeng; Tina W F Ho; Kwok-Pui Fung; Ping-Chung Leung; Ning-Hua Tan; Clara B S Lau
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Suppression of stretch reflex activity after spinal or systemic treatment with AMPA receptor antagonist NGX424 in rats with developed baclofen tolerance.

Authors:  Masakatsu Oshiro; Michael P Hefferan; Osamu Kakinohana; Nadezda Lukacova; Kazuhiro Sugahara; Tony L Yaksh; Martin Marsala
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Expression and function of the K+ channel KCNQ genes in human arteries.

Authors:  Fu Liang Ng; Alison J Davis; Thomas A Jepps; Maksym I Harhun; Shuk Yin Yeung; Andrew Wan; Marcus Reddy; David Melville; Antonio Nardi; Teck K Khong; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

7.  Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).

Authors:  X P Chen; W Yang; Y Fan; J S Luo; K Hong; Z Wang; J F Yan; X Chen; J X Lu; J L Benovic; N M Zhou
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

8.  Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels.

Authors:  Heng Yu Zhang; Ping Liao; Jue Jin Wang; De Jie Yu; Tuck Wah Soong
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

9.  Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2.

Authors:  A Lundby; T Jespersen; N Schmitt; M Grunnet; S-P Olesen; J M Cordeiro; K Calloe
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

10.  Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Authors:  F Wunder; H Tinel; R Kast; A Geerts; E M Becker; P Kolkhof; J Hütter; J Ergüden; M Härter
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.